✦ LIBER ✦

Comparison of Anti-Estrogen Receptor Antibodies SP1, 6F11, and 1D5 in Breast Cancer: Lower 1D5 Sensitivity but Questionable Clinical Implications

✍ Scribed by Bogina, G.; Zamboni, G.; Sapino, A.; Bortesi, L.; Marconi, M.; Lunardi, G.; Coati, F.; Massocco, A.; Molinaro, L.; Pegoraro, C.; Venturini, M.

Book ID: 120493818
Publisher: American Society for Clinical Pathology
Year: 2012
Tongue: English
Weight: 914 KB
Volume: 138
Category: Article
ISSN: 0002-9173
DOI: 10.1309/AJCPLX0QJROV2IJG

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of immunohistochemical analys

Comparison of immunohistochemical analysis with estrogen receptor SP1 and 1D5 monoclonal antibodies in breast cancer

✍ Madeira, Klesia Pirola; Daltoé, Renata Dalmaschio; Sirtoli, Gabriela Modenesi; R 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 675 KB

21 COMPARISON OF ESTROGEN RECEPTOR EXPRE

21 COMPARISON OF ESTROGEN RECEPTOR EXPRESSION IN BREAST CANCER CELLS BY IMMUNOHISTOCHEMISTRY USING THE MONOCLONAL ANTIBODIES SP1 AND 1D5

✍ Madeira, K.P.; Daltoe, R.D.; Sirtoli, G.M.; Rezende, L.C.D.; Assis, A.; Silva, I 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 91 KB

1D5 and 6F11: An Immunohistochemical Com

1D5 and 6F11: An Immunohistochemical Comparison of Two Monoclonal Antibodies for the Evaluation of Estrogen Receptor Status in Primary Breast Carcinoma

✍ Kaplan, Paul A.; Frazier, Shellaine R.; Loy, Timothy S.; Diaz-Arias, Alberto A.; 📂 Article 📅 2005 🏛 American Society for Clinical Pathology 🌐 English ⚖ 88 KB

Comparison of estrogen receptor determin

Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials

✍ Steven R. Alberts; James N. Ingle; Patrick R. Roche; Stephen S. Cha; Lester E. W 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 830 KB

## BACKGROUND. The measurement of estrogen receptors (ER) in breast cancer specimens has traditionally been assessed with a tlextran-coated charcoal assay (DCCA). More recently the immunohistochemical staining (IHC) method has gained increasing popularity because of its ability to use fixed tissue